Condition: Metastatic Gastric Adenocarcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Peritoneal Carcinomatosis · Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
This is a multi-center, non-randomized, 3-cohort, phase II trial, evaluating a triplet combination of docetaxel, oxaliplatin and fluorouracil for gastric cancer with peritoneal carcinomatosis and inoperable malignant bowel obstruction.
This description comes directly from the study's public registry record.
Jian Xiao, MD · 86-20-81884713 · xiao_jian@139.com
Always discuss trial participation with your own doctor first.
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04840264